Global Blood Therapeutics (GBT) Files $250M Mixed Securities Shelf

October 14, 2016 6:07 AM EDT

Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.

Global Blood Therapeutics (Nasdaq: GBT) filed a registration with the U.S. SEC to sell up to $250 million of mixed securities.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Equity Offerings

Add Your Comment